Sale!

TGM6 Gene Spinocerebellar Ataxia Type 35 Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TGM6 Gene Spinocerebellar Ataxia Type 35 (SCA35) Autosomal Dominant Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the TGM6 gene, which are associated with Spinocerebellar Ataxia Type 35. SCA35 is a neurodegenerative disorder characterized by a wide range of symptoms including coordination and balance difficulties, speech problems, and a gradual deterioration of motor skills. This condition is inherited in an autosomal dominant manner, meaning that an individual only needs a single copy of the mutated gene from one parent to be affected.

The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect the presence of specific mutations in the TGM6 gene. It is a crucial tool for families with a history of SCA35, as it can provide definitive diagnosis of the condition, inform about the risk of passing the gene to offspring, and assist in the management and treatment planning for affected individuals.

The cost of the TGM6 Gene Spinocerebellar Ataxia Type 35 Autosomal Dominant Genetic Test at DNA Labs UAE is 4400 AED. This investment in genetic testing can offer invaluable information for affected individuals and their families, guiding healthcare decisions and providing insights into the genetic underpinnings of their condition.

Description

TGM6 Gene Spinocerebellar ataxia type 35 autosomal dominant Genetic Test

Components: TGM6 Gene Spinocerebellar ataxia type 35 autosomal dominant Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for TGM6 Gene Spinocerebellar ataxia type 35, autosomal dominant NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TGM6 Gene Spinocerebellar ataxia type 35, autosomal dominant.

Test Details: Spinocerebellar ataxia type 35 (SCA35) is a rare genetic disorder characterized by progressive ataxia, which affects coordination and balance. It is an autosomal dominant disorder, meaning that an affected individual has a 50% chance of passing on the condition to each of their children. The TGM6 gene is associated with SCA35. Mutations in this gene can lead to the development of the disorder. The TGM6 gene provides instructions for making an enzyme called transglutaminase 6, which is involved in the development and maintenance of neurons in the cerebellum. To diagnose SCA35, a Next-Generation Sequencing (NGS) genetic test can be performed. This test analyzes the individual’s DNA to identify any mutations or variations in the TGM6 gene. NGS technology allows for the simultaneous analysis of multiple genes, providing a comprehensive assessment of genetic variants associated with ataxias. The NGS genetic test for SCA35 can help confirm a diagnosis in individuals with suspected ataxia and a family history of the disorder. It can also be used for genetic counseling, as it provides information about the risk of passing on the condition to future generations. It is important to note that genetic testing for SCA35 should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.

Test Name	TGM6 Gene Spinocerebellar ataxia type 35 autosomal dominant Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for TGM6 Gene Spinocerebellar ataxia type 35, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with TGM6 Gene Spinocerebellar ataxia type 35, autosomal dominant
Test Details	Spinocerebellar ataxia type 35 (SCA35) is a rare genetic disorder characterized by progressive ataxia, which affects coordination and balance. It is an autosomal dominant disorder, meaning that an affected individual has a 50% chance of passing on the condition to each of their children. The TGM6 gene is associated with SCA35. Mutations in this gene can lead to the development of the disorder. The TGM6 gene provides instructions for making an enzyme called transglutaminase 6, which is involved in the development and maintenance of neurons in the cerebellum. To diagnose SCA35, a Next-Generation Sequencing (NGS) genetic test can be performed. This test analyzes the individual’s DNA to identify any mutations or variations in the TGM6 gene. NGS technology allows for the simultaneous analysis of multiple genes, providing a comprehensive assessment of genetic variants associated with ataxias. The NGS genetic test for SCA35 can help confirm a diagnosis in individuals with suspected ataxia and a family history of the disorder. It can also be used for genetic counseling, as it provides information about the risk of passing on the condition to future generations. It is important to note that genetic testing for SCA35 should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.